Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts
Andrea Pilotto(Fondazione Europea Ricerca Biomedica), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Gerhard W. Eschweiler(University Children's Hospital Tübingen), Rezzak Yılmaz(Hertie Institute for Clinical Brain Research), Stefanie Lerche(German Center for Neurodegenerative Diseases), Sebastian Heinzel(Christian-Albrechts-Universität zu Kiel), Anna‐Katharina von Thaler(Christian-Albrechts-Universität zu Kiel), Ulrike Suenkel(Hertie Institute for Clinical Brain Research), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Eva Schaeffer(Christian-Albrechts-Universität zu Kiel), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), Benjamin Röeben(German Center for Neurodegenerative Diseases), Isabel Wurster(German Center for Neurodegenerative Diseases), Florian G. Metzger(University Children's Hospital Tübingen), Ron B. Postuma(Montreal General Hospital), Kathrin Brockmann(Oregon Health & Science University)
Cited by 97
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846